Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: A sequential, randomized, double-blind clinical trial
- Resource Type
- Article
- Source
- In
Clinical Therapeutics 2007 29(4):602-610 - Subject
- Language
- ISSN
- 0149-2918